'The World Professional Association for Transgender Health (WPATH) Standards of Care Version 7 (SOCv7)30 represent normative standards for clinical care, acting as a benchmark in this field.31 Globally, many national and local guidelines are adaptations of, acknowledge being influenced by, or are intended to complement WPATH SOCv7,30 despite expressed reservations that WPATH SOCv730 is based onlower-quality primary research, the opinions of experts
and lacks grading of evidence.36 In the UK, an advocacy group worked to incorporate WPATH SOCv730 into national practice.37 WPATH SOCv730 informs National Health Service (NHS) gender identity clinics38 and guidelines produced by the Royal College of Psychiatrists (without use of GRADE).39 No
CPGs were available from the National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), British Association of
Gender Identity Specialists, or medical Royal Colleges, although the Royal College of General Practitioners issued a position statement on gender minority/trans healthcare in 2019.40 Assessing quality of international
CPGs such as WPATH SOCv7 30 has practice implications for the NHS 38 and private sector.'
Apologies the formatting is all a bit wonky. Bolding is mine.
This is from 'International clinical practice guidelines for gender minority/trans people: systematic review and quality assessment' in BMJ
https://bmjopen.bmj.com/content/11/4/e048943
Some more quotes. This review was scathing about the quality of CPGs, including WPATH:
'WPATH SOCv7 cannot be considered ‘gold standard’'
'WPATH SOCv7 originated nearly a decade ago from a special-interest
association; diagnostic criteria and CPG methodology have since changed. ...it is puzzling to have found so little else, maybe suggesting CPGs for gender minority/trans people have been driven by provider-interests rather than healthcare needs.'
'Clinicians should be made aware that gender minority/trans health CPGs outside of HIV-relatedtopics are linked to a weak evidence base, with variations in methodological rigour and lack of stakeholder involvement. While patient care plans ought to take into account the individual needs of each gender minority/trans person, a gap appears to exist between clinical practice and research in this field.78 Clinicians should proceed with caution, explain uncertainties to patients and recruit to research'
That is all of course relating to SoC v 7. Has there been any assessment of SoC v 8 from NICE or NHS?